Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (39031)	8/31/2010 10:40:23 PM
From: Paul Senior	Read Replies (1) \| Respond to of 78671

Fill for me today for more DGX as it continues to fall. Low p/sales, low p/e, etc. Aside: If I were SNY, I'd consider acquiring DGX. You get the get the good earnings from an established business and maybe growth resumption as more people age and possibly have more diagnostic tests. Possibly DGX would lose some business from SNY competitors who otherwise might hire an independent DGX, but I would guess there still would be a huge database of information in DGX that SNY could mine for clues as to where SNY could direct its (SNY's) research or other acquisitions. finance.yahoo.com